机译:Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials
Univ Auckland, Fac Med, Auckland, New Zealand;
Bordeaux Univ Hosp, Ctr Invest Fibrose Hepat, Pessac, France;
AbbVie Inc, N Chicago, IL USAASST Fatebenefratelli Sacco, Div Infect Dis 1, Milan, ItalyBon Secours Mercy Hlth, Liver Inst Virginia, Richmond, VA USAGlasgow Royal Infirm, Dept Gastroenterol, Glasgow, Lanark, ScotlandHosp Univ Puerta Hierro, Dept Gastroenterol & Hepatol, Madrid, SpainScripps Ctr Organ & Cell Transplantat, La Jolla, CA USA;
care cascade; concordance; direct-acting antivirals; hepatitis C virus; sustained virologic response;